Opinion: Whale songs: the sounds of love and loss as heard by an OB-GYN
“I have developed a trained ear for many kinds of ‘humanized’ whale songs especially the types sung by women,” writes…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 283 articles · page 4 of 8 · fetched 22 minutes ago
Opinion: Cancer screening guidelines need to address long-term care facilities
After her aunt died, cancer epidemiologist Kim Johnson looked into screening guidelines for long-term care residents —…
Read at source →
How Trump’s cuts are reshaping America’s health system
A scramble to prepare for massive federal cuts across the health care system is hitting rural states like Maine…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
STAT+: Lady Gaga and her fiancé launch a biotech startup
FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more…
Read at source →
STAT+: Public-sector purgatory, and a union-hospital fight
Aon, the big consulting and brokerage house, confirms 2027 is going to be brutal for job-based health care premiums.…
Read at source →
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is…
Read at source →
FDA plans to regulate generative AI
New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds
Read at source →
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
Read at source →
STAT+: Inside Moderna and Merck’s cancer vaccine triumph
Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges,…
Read at source →
STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs
The legal theory used to restrict gender-affirming care for minors could be applied broadly, experts say.
Read at source →
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s…
Read at source →
Nurse practitioner trainees find themselves stymied by shortage of clinical mentors
Nurse practitioner students face a preceptor shortage, often paying thousands to secure clinical supervision.
Read at source →
Opinion: Medicine stopped shaking hands. We should start again
A handshake takes only a few seconds but can make a major difference to a patient, an emergency physician writes.
Read at source →
Opinion: I’m a retired doctor. Volunteering at a community clinic gave me an entirely new medical education
“It was only after retiring from mainstream medicine when I fully comprehended the callous limitations of our health…
Read at source →
Americans bought 12% less soda under new SNAP restrictions, study says
The drop in soda purchases is meaningful, but not enormous, one of the study's authors said.
Read at source →
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
Kennedy asks for feedback on new vaccine recommendation categories, how shots are tested.
Read at source →STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon
Read at source →
STAT+: Are cancer patients getting too much drug?
Moderna's stunning surge and drop, AI in scientific writing, and more biotech news from The Readout
Read at source →
Scientists deploy Merck’s Ebola vaccine in DRC
Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds
Read at source →
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional…
Read at source →
Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment
We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement.
Read at source →
Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors
Long-term survivors deserve to see a cure, not fear the losses it might bring.
Read at source →
STAT+: How a Trump loyalist got the FDA nomination
What you need to know about Heidi Overton, and Erica Schwartz's first speech to CDC staff.
Read at source →
STAT+: FDA approves Ultragenyx gene therapy
Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The…
Read at source →
Contrasting legal decisions on gender-affirming care
Heidi Overton's rise under Trump, inside a 5-year-old brain organoid, and other health news from Morning Rounds
Read at source →STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval,…
Read at source →
STAT+: One of the most consequential years for cancer treatment, ever
Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner…
Read at source →
STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
Read at source →
STAT+: How health systems are embracing chatbots to query and summarize patient records
Several large health systems are rolling out AI chatbots to query patient records, because they can save time and…
Read at source →
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son…
Read at source →
Reduce protein to increase longevity? Nutrition experts say that’s a bad idea
Reducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several…
Read at source →
Can reclassifying muscle dysmorphia unlock better care for boys and men?
Males make up about a third of the population struggling with eating disorders in the United States. While these…
Read at source →
Opinion: The global health aid architecture is collapsing. The faith economy isn’t
“Washington has rediscovered faith as a delivery mechanism. The bigger opportunity is faith as a source of capital,”…
Read at source →
STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA
If she wins confirmation as FDA commissioner, Heidi Overton will face plenty of big challenges.
Read at source →
STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’
Then new CDC director told staff she is “very comfortable and very confident ... [in] speaking truth to power.”
Read at source →
Trust in science: A new STAT initiative
Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver…
Read at source →